News Releases January 13, 2021 – Imagin Medical Builds Momentum for 2021 November 10, 2020 – Imagin Medical Closes First Tranche of Convertible Notes Offering October 22, 2020 – Imagin Medical Announces Agenda for KOL Virtual Investor Event on October 29, 2020 October 22, 2020 – Imagin Medical Announces Proposed Offering of $3 Million of Convertible Notes and Share Consolidation October 7, 2020 – Imagin Medical Selects Lighthouse Imaging as i/Blue Imaging System Contract Manufacturer September 29, 2020 – Imagin Medical to Host KOL Webcast Event on October 29, 2020 August 28, 2020 – Imagin Medical Reports Fiscal 2020 Third Quarter Results July 15, 2020 – Imagin Medical To Begin Testing of i/Blue Imaging System on Anatomical Bladder Models May 28, 2020 – Imagin Medical Imagin Medical Reports Fiscal 2020 Second Quarter Results May 21, 2020 – Imagin Medical To Report Second Fiscal Quarter 2020 Financial Results on May 28, 2020 – Conference Call May 21, 2020 – Imagin Medical Announces Successful Delivery of Functional i/Blue Imaging System May 14, 2020 – Imagin Medical Reports Response to Covid-19 May 12, 2020 – Imagin Medical Supports Cancer Awareness Month April 9, 2020 – Imagin Medical Receives Approval to Reprice and Extend Term of Warrants February 10, 2020 – Imagin Medical Reports Physician Feedback on i/Blue Imaging System for Bladder Cancer Visualization February 27, 2020 – Imagin Medical Reports Fiscal 2020 First Quarter Results February 20, 2020 – Imagin Medical to Report First Fiscal Quarter 2020 Financial Results on February 27, 2019 – Conference Call to Follow February 10, 2020 – Imagin Medical to Present at NobleCon16 January 23, 2020 – Imagin Medical Finishes 2019 Strong and Provides Insight into 2020 and Beyond January 21, 2020 – Imagin Medical Closes Oversubscribed Private Placement January 10, 2020 – Imagin Medical Announces Stock Option Grant January 8, 2020 – Imagin Medical Reports Successful Completion of Design Verification and Announces Private Placement December 24, 2019 – Imagin Medical Reports Fiscal Year End 2019 Results December 18, 2019 – Imagin Medical Announces Results of Annual Meeting of Shareholders December 3, 2019 – Imagin Medical to Present at the First Annual BIOTuesdays Pre-JPM Virtual Conference November 12, 2019 – Imagin Medical Confirms Functional Units on Schedule for Products Design Verification October 17, 2019 – Imagin Medical Announces Social Media Campaign Launch September 26, 2019 – Imagin Medical Announces Meeting Regarding i/Blues’s Regulatory Pathway August 27, 2019 – Imagin Medical Reports Fiscal 2019 Third Quarter Results July 15, 2019 – Imagin Medical Progress Update June 24, 2019 – Imagin Medical Announces Stock Option Grant June 11, 2019 – Imagin Medical Reports Fiscal 2019 Second Quarter Financial Results June 6, 2019 – Imagin Medical to Report Fiscal 2019 Second Quarter Results on June 11, 2019 – Conference Call to Follow April 17, 2019 – Imagin Medical Welcomes World-Renowned Bladder Cancer Expert Dr. Ashish Kamat to Its Scientific Board of Advisors April 2, 2019 – Imagin Medical Completes Assembly of i/Blue Imaging Functional Unit February 27, 2019 – Imagin Medical Reports Fiscal Q1 2019 Results February 19, 2019 – Imagin Medical to Report Fiscal Q1 2019 Results on February 27, 2019 – Conference Call to Follow January 23, 2019 – Imagin Medical to Present at Noble Capital Markets 15th Annual Investor Conference January 9, 2019 – Imagin Medical Posts New Presentation on Its Website December 20, 2018 – Imagin Medical Reports Fiscal Year End 2018 Results December 18, 2018 – Imagin Medical Announces Results of Annual Meeting of Shareholders November 28, 2018 – Imagin Medical Comments on Recent Promotional Activity Pursuant to OTC Markets Request October 31, 2018 – Imagin Medical Receives Approximately $1 from Exercise of Warrants October 2, 2018 – Imagin Medical Announces Changes to its Board of Directors August 14, 2018 – Imagin Medical Reports Fiscal 2018 Third Quarter Results July 25, 2018 – Imagin Medical Announces Stock Options Granted July 17, 2018 – Imagin Medical Reports Research Study Progress June 27, 2018 – Imagin Medical Announces Uplisting to OTCQB June 22, 2018 – Imagin Medical Provides Further Details on Kilmer Lucas Engagement June 21, 2018 – Imagin Engages Kilmer Lucas for Cross-border Investor Relations April 26, 2018 – Imagin Gains Momentum; Positive Progress in Research Study April 19, 2018 – IME Closes Oversubscribed Private Placement April 12, 2018 – Imagin Medical Closing Private Placement April 3, 2018 – Imagin Medical Announces Private Placement March 8, 2018 – Imagin Medical Closes Private Placement March 7, 2018 – Imagin Medical Product Re-Design on Schedule March 1, 2018 – Imagin Medical Announces Private Placement February 26, 2018 – Imagin Medical Appoints Director of Regulatory Affairs February 15, 2018 – Imagin Medical Closes Private Placement February 9, 2018 – American Urological Association (AUA) Honors Imagin Medical Scientific Advisor February 7, 2018 – University of Rochester Initial Research Study Patients Completed January 30, 2018 – Imagin Medical Announces Private Placement January 30, 2018 – John Vacha Joins Imagin Medical Board of Directors January 22, 2018 – Imagin Medical Research Study Begins January 17, 2018 – Imagin Medical Stock Options Granted January 15, 2018 – Imagin Medical Recruits Senior Healthcare CFO January 9, 2018 – Imagin Medical Builds Momentum for 2018 January 9, 2018 – Imagin Medical Stock Option Granted December 14, 2017 – Imagin Medical Stock Options Granted December 8, 2017 – Imagin Medical Investors Exercise Warrants Generating $1M November 29, 2017 – Imagin Medical Opens Enrollment for Research Study November 28, 2017 – Imagin Medical Stock Options Granted November 9, 2017 – Prototype Redesign November 6, 2017 – Enhanced Cystoscopy Improves Bladder Cancer Detection October 27, 2017 – Imagin Medical Scientific Advisor Attends Society of International Urology Meeting October 26, 2017 – Imagin Medical Announces Stock Options Granted October 26, 2017 – Imagin Medical Announces PP for Communications October 19, 2017 – Imagin Medical Announces Clinical Research Criteria October 18, 2017 – Imagin Medical Closed $1M Private Placement October 13, 2017 – Imagin Medical Closing 2nd and Final Tranche of $1M Private Placement October 11, 2017 – Urologists Invest in Imagin Medical Private Placement October 5, 2017 – Clinical Research Study Listed on Government Website October 4, 2017 – Imagin Medical Closing Tranche 1 and Increasing Private Placement Offering September 27, 2017 – Imagin Medical Receives 1st In-Human Research Study Approval September 26, 2017 – Imagin Medical Announces Private Placement June 28, 2017 – 2017 Mid Year Update April 10, 2017 – New Release – Imagin Medical Grants Stock Options March 3, 2017 – New Release – Imagin Medical Closes Private Placement of Convertible Notes March 2, 2017 – New Release – Imagin Medical Final Product Design on Track February 24, 2017 – Imagin Medical Arranges Private Placement of Convertible Notes February 22, 2017 – New Release – Imagin Medical Signs $8M Term Sheet with New York Private Equity Firm Alumina Partners LLC February 9, 2017 – New Release – Imagin Medical Technology Presented at Photonics West 2017 January 10, 2017 – New Release – Imagin Medical Poised for 2017 Success December 9, 2016 – News Release – Imagin Medical Closes Tranche 2 of Private Placement December 8, 2016 – News Release – Imagin Medical Chooses Optel, Inc. to Design i/Blue Prototype for Commercialization December 1, 2016 – News Release – Imagin Medical Completes Alpha B Prototype November 10, 2016 – News Release – Dr. Roger Buckley Joins Imagin Medical’s Scientific Board of Advisors October 27, 2016 – News Release – Dr. Liam J. Hurley Joins Imagin Medical’s Scientific Board of Advisors October 20, 2016 – News Release – Imagin Medical Closes Tranche 1 of Private Placement for $385,000 October 6, 2016 – News Release – Imagin Medical’s Quality Management System Initial Phase Complete September 29, 2016 – News Release – Ken Daignault Joins Imagin Medical’s Board of Directors September 22, 2016 – News Release – Dr. Edward Messing, Chief of Urology, U Rochester Medical Center Joins Imagin Medical’s Scientific Board of Advisors September 15, 2016 – News Release – Disruptive Technology Update September 13, 2016 – News Release – Imagin Medical Issues Private Placement August 1, 2016 – News Release – American Urological Association’s New Guidelines for Bladder Cancer Support Imagin Medical’s Objective July 20, 2016 – News Release – Alpha Prototype on Schedule June 9, 2016 – News Release – Imagin Signs Agreements to Support i/Blue Development: University of Rochester Laboratory of Laser Energetics and U.S. Department of Energy May 24, 2016 – News Release – Imagin Attended American Urological Association Annual Meeting May 10, 2016 – News Release – Imagin Medical Now Trading on Frankfurt and Stuttgart Exchanges May 5, 2016 – News Release – Imagin Medical Attends America Urology Association Annual Meeting April 28, 2016 – News Release – Imagin Medical Begins Trading on OTC April 24, 2016 – News Release – Imagin Announces Dr. Ralph deVere White Named Chairman of the Scientific Advisory Board April 12, 2016 – News Release – Imagin Announces i/Blue Product Development Program Moves to University of Rochester Laboratory for Laser Energetics (LLE) March 9, 2016 – News Release – Imagin Corporate Update – Prototype Development Launched with Boston Management Team February 23, 2016 – News Release – Imagin Medical Starts Trading On the CSE February 9, 2016 – News Release – Acquisition Closing December 10, 2015 – News Release – AGM results November 18, 2015 – 2015 – News Release – Update on Transaction with BSS October 5, 2015 – 2015 News Release re Definitive Agreement with BSS July 9, 2015 – 2015 – News Release – LOI with BSS
